Genipin crosslinking promotes biomechanical reinforcement and pro-regenerative macrophage polarization in bioartificial tubular substitutes
Metadatos
Mostrar el registro completo del ítemAutor
Berasain, Jone; Ávila-Fernández, Paula; Cárdenas Pérez, Rocío; Cànaves Llabrés, Antoni Ignasi; Etayo Escanilla, Miguel; Alaminos Mingorance, Miguel; Carriel Araya, Víctor; García García, Óscar Darío; Chato Astrain, Jesús; Campos Sánchez, FernandoEditorial
Elsevier
Materia
Peripheral nerve Fibrin-agarose Genipin
Fecha
2024-03-21Referencia bibliográfica
J. Berasain et al. 174 (2024) 116449. [https://doi.org/10.1016/j.biopha.2024.116449]
Patrocinador
FIS PI20/ 00318, PI23/00337 and PI22/00059, co-financed by FEDER funds (European Union); CPP2021–009070 by the “Proyectos de colaboración público-privada, Plan de Investigación Científica, Técnica y de innovación 2021–2023, Ministerio de Ciencia e Innovación, Unión Europea, Agencia Estatal de Investigación, España; PPJIA2022-19 “Ayudas del plan propio UGR 2022, Plan propio de investigación y transferencia, Universidad de Granada, España”.Resumen
Traumatic nerve injuries are nowadays a significant clinical challenge and new substitutes with adequate biological
and mechanical properties are in need. In this context, fibrin-agarose hydrogels (FA) have shown the
possibility to generate tubular scaffolds with promising results for nerve repair. However, to be clinically viable,
these scaffolds need to possess enhanced mechanical properties. In this line, genipin (GP) crosslinking has
demonstrated to improve biomechanical properties with good biological properties compared to other crosslinkers.
In this study, we evaluated the impact of different GP concentrations (0.05, 0.1 and 0.2% (m/v)) and
reaction times (6, 12, 24, 72 h) on bioartificial nerve substitutes (BNS) consisting of nanostructured FA scaffolds.
First, crosslinked BNS were studied histologically, ultrastructurally and biomechanically and then, its biocompatibility
and immunomodulatory effects were ex vivo assessed with a macrophage cell line. Results showed that
GP was able to improve the biomechanical resistance of BNS, which were dependent on both the GP treatment
time and concentration without altering the structure. Moreover, biocompatibility analyses on macrophages
confirmed high cell viability and a minimal reduction of their metabolic activity by WST-1. In addition, GPcrosslinked
BNS effectively directed macrophage polarization from a pro-inflammatory (M1) towards a proregenerative
(M2) phenotype, which was in line with the cytokines release profile. In conclusion, this study
considers time and dose-dependent effects of GP in FA substitutes which exhibited increased biomechanical
properties while reducing immunogenicity and promoting pro-regenerative macrophage shift. These tubular
substitutes could be useful for nerve application or even other tissue engineering applications such as urethra.